NEAL KLEIMAN to Injections, Subcutaneous
This is a "connection" page, showing publications NEAL KLEIMAN has written about Injections, Subcutaneous.
Connection Strength
0.022
-
Enoxaparin 0.3 mg/kg IV supplement for patients transitioning to PCI after subcutaneous enoxaparin therapy for NSTE ACS: a subgroup analysis from the SYNERGY trial. Catheter Cardiovasc Interv. 2010 May 01; 75(6):928-35.
Score: 0.022